Should I hold Barclays in an ISA or a SIPP?

For most UK investors the wrapper matters more than the stock. Barclays pays a modest dividend and runs large buybacks, so both income and capital gains are in play. Inside a Stocks and Shares ISA all dividends and gains are tax free, which suits investors who may sell within a few years. A SIPP also shelters the same returns but locks the money away until at least age 55, rising to 57 from 2028, so it fits long term retirement compounding. Neither wrapper changes Barclays as a business, only how much of the return you keep.

What do RoTE and tangible book value mean for a bank?

Return on tangible equity, or RoTE, measures profit as a percentage of the bank's tangible equity, which is shareholder capital stripped of goodwill and intangibles. It is the headline profitability gauge for banks, much like return on capital elsewhere. Tangible net asset value, or TNAV, is that same tangible equity expressed per share. When a bank trades above 1x TNAV, as Barclays now does at about 1.25x, the market is paying a premium to book value because it expects returns above the bank's cost of equity. A rising RoTE is what justifies a rising price to TNAV multiple.

Is Barclays a good income stock?

On the ordinary dividend alone, not really. The trailing yield sits under 2%, below the FTSE 100 average of roughly 3.5%, so income-focused investors will typically find a higher yield elsewhere in the banking sector. The bigger part of Barclays' shareholder return comes from buybacks, with over £15bn of total capital returns planned across 2026 to 2028. Buybacks lift earnings per share and can be tax efficient, but they are less predictable than a cash dividend and only add value while the shares trade below tangible book. Barclays' total return case rests more on buybacks than on the ordinary yield.

How does Openbook calculate the Reward Score?

The Reward Score runs from 0 to 100 and blends four weighted factors: Growth at 40%, Momentum at 25%, Profitability at 20% and Valuation at 15%. Each factor is built from underlying metrics, for example revenue and earnings growth, price performance versus the benchmark, margins and returns, and valuation multiples. A higher score signals a stronger reward setup on the model's reading. It is a relative ranking tool, not a price target, and should be read alongside the Risk Score rather than on its own.

Could the motor finance redress hurt Barclays?

It is a known overhang rather than a hidden one. Barclays has already raised its motor finance provision to £325m and booked a further charge in Q1 2026. The size of any final industry bill depends on the FCA's redress scheme, and a higher number of eligible cases or a higher cost per claim would mean more provisions. The risk is manageable against a bank generating billions in annual profit, but it adds noise to quarterly results and could delay or trim buybacks if the figure climbs. Watch the running provision at each results date.

Barclays (BARC) Stock Analysis 2026: Re-rated But Still Cheap?

Barclays is the FTSE 100's re-rating story that has already partly played out. This Barclays stock analysis starts with the tension every buyer now faces. Over the past year the shares have climbed more than half, as investors finally accepted that a universal bank spanning UK retail, US cards and a bulge bracket investment bank could actually hit its return targets. First quarter 2026 delivered a 13.5% return on tangible equity, ahead of the full year target of above 12%, with every division posting double digit returns. Openbook now scores Barclays a reward of 69, a HIGH reading in the top quarter of all stocks, against a moderate risk score of 49, and tags it a Quality Compounder. The cheap bank thesis worked. At about 1.3 times tangible book the easy re-rating is behind the stock, yet Barclays still trades below both the wider FTSE 100 and its European bank peers. The question is where the next leg comes from.

What Barclays does

Barclays runs five divisions. Barclays UK is the ring fenced retail and business bank, including Barclaycard and the acquired Tesco Bank book. Alongside it sit the UK Corporate Bank, the Private Bank and Wealth Management arm, the Investment Bank, and the US Consumer Bank. The group has two home markets, the UK and the US. The mix is the point. Roughly half of Barclays is steady domestic retail and corporate banking, and half is the more cyclical, dollar sensitive investment bank and US cards operation. For a UK investor, Barclays is the one large domestic bank that also hands you direct exposure to Wall Street trading revenues and US consumer credit. That cuts both ways.

Reward Score, the read

On growth, Barclays screens well. Full year 2025 income rose 9% to £29.1bn, profit before tax climbed 13% to £9.1bn, and earnings per share jumped 22% to 43.8p, flattered by a shrinking share count. Management guides 2026 income to about £31bn, and net interest income has now grown for eight consecutive quarters. A structural hedge with £18.3bn of gross income locked in for 2026 to 2028 gives that growth unusual visibility for a bank. The catch is that part of the per share growth is manufactured by buybacks rather than pure business expansion.

Momentum has done the heavy lifting. The shares are up around half over a year, and UK banks led the FTSE 100 higher through 2025. Sell side sentiment is firmly positive, with a Strong Buy consensus and price targets clustered around 550p to 560p. This is the factor most likely to cool, because momentum this strong rarely repeats from a re-rated base.

Profitability is improving and that is the real engine. RoTE rose from 11.3% in 2025 to 13.5% in the first quarter of 2026, with a target of above 14% by 2028. The cost to income ratio improved to 56%, and all five divisions cleared double digit returns. Bank profitability is capital hungry, though, and the investment bank still drags group RoTE below the levels pure domestic peers such as NatWest achieve.

Valuation is where the story gets finely balanced. Barclays trades on roughly 9 times forward earnings and about 1.3 times tangible book, having re-rated from a sector that sat near 5.4 times only two years ago. That is still a discount of around a quarter to the wider FTSE 100 and below European banks nearer 10 times. Cheap on an absolute basis, yes. A deep value screamer, no longer.

Risk Score, the read

The headline risk score of 49 is moderate, and notably the lowest of the four UK bank majors, with four metrics flagged. Capital is strong, with a CET1 ratio of 14.1% providing a comfortable buffer, and liquidity metrics are healthy. The offset is earnings volatility from the investment bank and US consumer credit, which makes reported results lumpier than a domestic only lender.

The single factor to watch is credit and conduct noise. First quarter impairments jumped to £823m, a loan loss rate of 74bps, above the 50 to 60bps through the cycle range. Most of that spike was a £228m single name charge tied to a sophisticated fraud in the securitised products book, which also raises fair questions about risk controls. Layer on a motor finance provision now at £325m and continued normalisation in US card losses, and the near term credit picture carries more uncertainty than the clean profitability numbers suggest.

What the market is missing

Consensus has settled on a simple line: UK banks are cheap, keep buying. That view is not wrong, but it lumps very different banks together. Openbook does not. It tags Barclays a Quality Compounder, while NatWest carries a Dividend King label and both Lloyds and Standard Chartered read as Shooting Stars. That split matters. The ordinary dividend yield on Barclays is genuinely low at under 2%, well below the FTSE 100 average and well below NatWest at over 4%, so income focused retirees buying Barclays for its payout are really buying a buyback story dressed as a bank. And the buyback engine only creates value while the shares trade below tangible book. Repurchasing stock at 1.25x TNAV is far less accretive than at the 0.4x levels of a few years ago. If the re-rating pushes the multiple toward 1.4x, the same rising price that investors are cheering quietly erodes the per share magic of every buyback. That feedback loop is the part the bull case tends to skip.

The analytical view

Barclays has won the argument on execution. The tension now is price, not quality. The next catalyst is the H1 2026 results on 28 July, and two numbers decide the read: group RoTE, which needs to stay above 12% and ideally trend toward the 2028 goal, and the loan loss rate, which will show whether 74bps was a one off single name event or the start of a credit trend. The compounding case from here rests on hedge-backed income and continued buybacks; the cheaper-entry case rests on a pullback toward tangible book, or firmer evidence that credit costs are contained.